Pediatrics
Credentials: Identifier: NPI 1619227899 · License: PA
A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain
Pain · 2016 · 177 citations
APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of…
Pain Practice · 2019 · 153 citations
APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of…
Journal of Pain Research · 2019 · 139 citations
Eugene Viscusi
3 papers
Neil Singla
Dennis Ruff
2 papers
Lynn Webster
Guillermo Valenzuela
1 paper
Harold Minkowitz
Marcy Powell
Mark Demitrack
Stephen Daniels
